Both hypoxia and IL-6 are able to transform non-stem cancer cells into cancer stem cells, and the intrinsic radioresistance of tumor stem cells may further explain the observed association between tumor hypoxia, IL-6 levels, and patient outcomes [44–47]. The gene discussed is IL6; the disease is neoplasm.